arrow
J

Jacob S. Young

University of San Francisco
H指数:35
被引数:4,848

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optical microscopy predictions of focal recurrence in glioblastoma

光学显微镜预测胶质母细胞瘤的局部复发

2026-09-250
OA
The role for surgery in IDH-mutant grade 4 astrocytomas: Interactive effects of resection, patient characteristics, and outcome—Report of the RANO resect group

IDH突变型4级星形细胞瘤中手术的作用:切除、患者特征和预后的交互影响——RANO切除组的报告

2026-08-310
PRE
Variation in meningioma recurrence risk estimates across observational cohorts: the influence of calendar time, WHO classifications, geographical settings, and healthcare systems

脑膜瘤复发风险估计值在不同观察队列中的差异:日历时间、WHO分类、地理环境和医疗系统的影响

2026-08-280
OAAI
Functional Gonadotroph Adenomas in Male Patients: Clinical Characteristics, Surgical Outcomes, and Hormonal Follow-up

功能性促性腺激素腺瘤在男性患者中的临床特征、手术结果及激素随访

2026-05-010
PRE
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group

IDH突变型2级胶质瘤切除范围的预后分类系统:一项由RANO resect group进行外部验证的国际、多中心、回顾性队列研究

2025-11-240
OAAI
Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30

在神经肿瘤学会成立30周年之际,回顾科学增长与创新

2025-11-040
PRE
Novel Dyrk1a inhibitors impair glioblastoma proliferation and enhance the effectiveness of other cell-cycle-directed therapies

新型Dyrk1a抑制剂抑制胶质母细胞瘤增殖并增强其他细胞周期导向疗法的有效性

2025-11-010
OAAI
Multivariate survival risk stratification in GBMs lacking necrosis and microvascular proliferation

胶质母细胞瘤中缺乏坏死和微血管增生的多变量生存风险分层

2025-11-010
OAAI
A coordinated care model for multidisciplinary meningioma treatment and research

多学科脑膜瘤治疗与研究的协同护理模型

2025-11-010
OAAI
Inter-rater agreement from an international expert panel on resectability of recurrent glioblastoma: a complementary post-hoc analysis of the prospective, randomized DIRECTOR trial

国际专家小组对复发性胶质母细胞瘤切除可行性的评定者间一致性:前瞻性、随机DIRECTOR试验的补充性事后分析

2025-11-010
OAAI
Trial in progress update: A phase 1/2 study of intracranial and intravenous multi-dosing of DB107-RRV (formerly Toca 511) and DB107-FC (5-fluorocytosine) in combination with radiation ± temozolomide (TMZ) in patients with newly diagnosed high-grade gliomas (HGGs)

试验进行中更新:一项关于DB107-RRV(原Toca 511)和DB107-FC(5-氟胞嘧啶)颅内及静脉多剂量给药,并与放疗联合±替莫唑胺(TMZ)治疗新诊断的高级别胶质瘤(HGGs)的1/2期研究。

2025-11-010
OAAI
SYNAPTIC REMODELING DRIVES IDH-MUTANT ASTROCYTOMA PROGRESSION AND EVOLUTION

突触重塑驱动IDH突变型星形细胞瘤的进展与演变

2025-11-010
PRE
TARGETING GLIOMA-NEURONAL CIRCUIT REMODELING TO OVERCOME IMMUNOSUPPRESSION: FUNCTIONAL AND THERAPEUTIC INSIGHTS

靶向胶质瘤-神经元回路重塑以克服免疫抑制:功能性与治疗性见解

2025-11-010
OAAI
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicenter, retrospective study with external validation by the RANO resect group

IDH突变型2级胶质瘤切除范围的预后分类系统:一项由RANO resect group进行外部验证的国际、多中心、回顾性研究

2025-11-010
PRE
DNA sequencing identifies NF1 variant classes associated with malignant peripheral nerve sheath tumor (MPNST) formation in neurofibromatosis type I

DNA测序识别与I型神经纤维瘤中恶性周围神经鞘瘤(MPNST)形成相关的NF1变异类别

2025-11-010
OAAI
The favorable associations between age and supramaximal resection with outcome in glioblastoma - a report of the RANO resect group

年龄与超最大切除对胶质母细胞瘤预后的有利关联——RANO切除组的报告

2025-11-010
OAAI
Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group

超切除与胶质母细胞瘤在不同年龄组中的预后关联:RANO切除组的报告

2025-10-250
PRE
PATIENT AGE IS RELATED TO FAVORABLE ASSOCIATION OF SUPRAMAXIMAL RESECTION WITH OUTCOME IN GLIOBLASTOMA - A REPORT OF THE RANO RESECT GROUP

患者年龄与超最大范围切除术在胶质母细胞瘤中良好结局的相关性——RANO切除组的报告

2025-10-010
OAAI